Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
8.81
0.00 (0.00%)
At close: Dec 5, 2025, 4:00 PM EST
9.08
+0.27 (3.06%)
After-hours: Dec 5, 2025, 7:01 PM EST
Corvus Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -15.08 | -62.29 | -27.03 | -41.31 | -43.24 | -6 | |
| Depreciation & Amortization | 0.1 | 0.09 | 0.15 | 0.37 | 0.46 | 0.63 | |
| Loss (Gain) From Sale of Assets | -0.01 | -0.01 | - | -0.02 | - | -37.46 | |
| Loss (Gain) From Sale of Investments | -1.33 | -1.14 | -0.89 | -0.17 | 0.24 | 0.15 | |
| Loss (Gain) on Equity Investments | 3.43 | 3.2 | 5.28 | 10.01 | 4.83 | 0.23 | |
| Stock-Based Compensation | 4.57 | 3 | 2.15 | 2.69 | 4.23 | 5.75 | |
| Other Operating Activities | -24.79 | 33.38 | - | - | - | - | |
| Change in Accounts Receivable | 0.04 | -0.05 | 0.56 | -0.08 | -0.51 | - | |
| Change in Accounts Payable | 0.1 | 1.06 | -0.45 | 0.41 | -1.9 | 1.02 | |
| Change in Other Net Operating Assets | 0.9 | -2.66 | -3.71 | 1.08 | -0.83 | 0.89 | |
| Operating Cash Flow | -32.07 | -25.42 | -23.94 | -27.02 | -36.72 | -34.78 | |
| Capital Expenditures | -0.15 | - | -0.03 | -0.27 | -0.01 | -0.08 | |
| Sale of Property, Plant & Equipment | 0.01 | 0.01 | - | 0.02 | - | - | |
| Investment in Securities | -24.62 | -27.49 | 15.58 | -23.03 | 21.57 | 44.85 | |
| Investing Cash Flow | -24.76 | -27.48 | 15.54 | -23.28 | 21.56 | 44.77 | |
| Issuance of Common Stock | 55.02 | 35.06 | 7.86 | - | 62.16 | 1.31 | |
| Other Financing Activities | - | 13.97 | - | - | - | - | |
| Financing Cash Flow | 55.02 | 49.03 | 7.86 | - | 62.16 | 1.31 | |
| Net Cash Flow | -1.81 | -3.88 | -0.54 | -50.3 | 47 | 11.3 | |
| Free Cash Flow | -32.22 | -25.42 | -23.97 | -27.29 | -36.72 | -34.85 | |
| Free Cash Flow Per Share | -0.43 | -0.42 | -0.50 | -0.59 | -0.88 | -1.18 | |
| Levered Free Cash Flow | -58.11 | 13.96 | -15.79 | -15.82 | -22.52 | -19.04 | |
| Unlevered Free Cash Flow | -58.11 | 13.96 | -15.79 | -15.82 | -22.52 | -19.04 | |
| Change in Working Capital | 1.04 | -1.65 | -3.59 | 1.41 | -3.24 | 1.91 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.